PMS41 - Cost-Effectiveness Of Denosumab In The Treatment Of Postmenopausal Osteoporosis (Pmo) Women In Mexico At High Risk Of Fractures And Intolerant To Oral Bisphosphonates
Autor: | Arocho, R., Rivera Hurtado, R., Salinas Escudero, G. |
---|---|
Zdroj: | In Value in Health May 2013 16(3):A225-A225 |
Databáze: | ScienceDirect |
Externí odkaz: |